Geoffrey Dusheiko Selected Research

DNA (Deoxyribonucleic Acid)

1/2021	Hepatitis B cure: How and when.
1/2020	Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients.
10/2018	Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose?
2/2015	Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).
1/2015	Towards the elimination and eradication of hepatitis B.
2/2012	Is there any value to hepatitis B virus genotype analysis?
3/2007	The role of cells refractory to productive infection in acute hepatitis B viral dynamics.
1/2006	Candidates for therapy: HBV.
3/2004	Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey Dusheiko Research Topics

Disease

23	Infections 01/2022 - 09/2002
20	Chronic Hepatitis B 11/2023 - 01/2003
17	Hepatitis B 08/2023 - 03/2004
12	Hepatitis C 01/2019 - 11/2007
12	Chronic Hepatitis C 01/2015 - 09/2002
9	Fibrosis (Cirrhosis) 01/2023 - 11/2007
8	Liver Diseases (Liver Disease) 11/2022 - 08/2009
6	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2013
4	Inflammation (Inflammations) 01/2019 - 09/2004
4	Anemia 01/2018 - 04/2009
3	Thrombocytopenia (Thrombopenia) 01/2022 - 11/2007
3	Persistent Infection 01/2019 - 06/2004
3	Chronic Disease (Chronic Diseases) 01/2018 - 08/2014
3	Disease Progression 01/2014 - 02/2012
3	Exanthema (Rash) 02/2012 - 04/2009
3	Virus Diseases (Viral Diseases) 06/2011 - 09/2002
2	Hepatitis 11/2022 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2015 - 01/2015
2	Coinfection 09/2015 - 01/2006
2	Pruritus (Itching) 02/2012 - 04/2009
1	Mental Disorders (Mental Disorder) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Fatty Liver 11/2022
1	Hemorrhage 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2015
1	Liver Failure 01/2015
1	Fatigue 08/2014
1	Eczema 02/2012
1	Dermatitis 02/2012
1	Cicatrix (Scar) 02/2012
1	Graves Disease (Basedow Disease) 08/2010
1	Thyroiditis 08/2010
1	Wounds and Injuries (Trauma) 03/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2009
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2009
1	Body Weight (Weight, Body) 04/2009
1	Hemolytic Anemia 01/2008
1	Headache (Headaches) 11/2007

Drug/Important Bio-Agent (IBA)

22	Antiviral Agents (Antivirals)IBA 11/2023 - 11/2007
17	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 03/2004
9	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2004
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2004
8	telaprevirIBA 01/2015 - 04/2009
7	Hepatitis B e AntigensIBA 01/2020 - 01/2003
7	InterferonsIBA 05/2015 - 11/2007
7	Interferon-alpha (Interferon Alfa)IBA 01/2014 - 03/2004
6	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2011
4	AntigensIBA 01/2022 - 09/2004
4	peginterferon alfa-2a (Pegasys)FDA Link 06/2011 - 03/2005
3	NucleosidesIBA 01/2021 - 02/2013
3	Lamivudine (Epivir)FDA Link 09/2015 - 03/2008
2	NucleotidesIBA 01/2020 - 01/2019
2	VaccinesIBA 01/2020 - 12/2017
2	SofosbuvirIBA 01/2019 - 08/2014
2	Tenofovir (Viread)FDA Link 09/2015 - 02/2015
2	SimeprevirIBA 01/2015 - 01/2011
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015 - 01/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2012 - 02/2011
2	Interleukin-10 (Interleukin 10)IBA 10/2012 - 12/2010
2	Peptides (Polypeptides)IBA 01/2012 - 09/2004
2	CytokinesIBA 12/2010 - 03/2007
2	Telbivudine FDA Link 03/2008 - 05/2007
1	Immunoglobulins (Immunoglobulin)IBA 08/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Ethanol (Ethyl Alcohol)IBA 11/2022
1	Aflatoxin B1 (Aflatoxin B)IBA 11/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	lusutrombopagIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Viral DNAIBA 01/2020
1	Circular DNAIBA 01/2020
1	ledipasvirIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	InterleukinsIBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2012
1	EmollientsIBA 02/2012
1	Galectins (Galectin)IBA 01/2012
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2010
1	LigandsIBA 12/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2010
1	Thrombopoietin (c-mpl Ligand)IBA 08/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2009
1	Inosine Triphosphate (ITP)IBA 08/2009
1	entecavir FDA Link 03/2008
1	adefovirIBA 03/2008
1	eltrombopag FDA Link 11/2007
1	Alanine Transaminase (SGPT)IBA 03/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	Proteins (Proteins, Gene)FDA Link 06/2004
1	adefovir dipivoxil (Hepsera)FDA Link 01/2003

Therapy/Procedure

36	Therapeutics 08/2023 - 09/2002
1	Secondary Prevention 11/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2022
1	Duration of Therapy 01/2020
1	Liver Transplantation 01/2019
1	Injections 01/2014
1	Retreatment 11/2011
1	Dental Care 03/2010
1	Immunotherapy 06/2004